Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction
- PMID: 9146812
- DOI: 10.1023/a:1024518730222
Effect of testosterone administration on sexual behavior and mood in men with erectile dysfunction
Abstract
This double-blind placebo controlled, cross-over study was carried out to assess the effect of testosterone administration on sexual behavior mood, and psychological symptoms in healthy men with erectile dysfunction. Biweekly injections of 200 mg of testosterone enanthate were given over a period of 6 weeks separated by a washout period of 4 weeks. Blood samples for hormonal assessment, behavioral and psychological ratings were obtained prior to each injection. Luteinizing hormone remained significantly depressed but circulating testosterone had returned to baseline levels by 2 weeks following each hormonal injection. The ejaculatory frequency during the testosterone phase was statistically higher than during the placebo phase. There were marked, although statistically nonsignificant, increases in median frequency of reported sexual desire, masturbation, sexual experiences with partner, and sleep erections during the testosterone period. Testosterone did not have demonstrable effects on ratings of penile rigidity and sexual satisfaction. Mood variables and psychological symptoms did not change following hormonal administration. Results suggest that androgen administration to eugonadal men with erectile dysfunction may activate their sexual behavior without enhancing erectile capacity and without effects on mood and psychological symptoms.
Similar articles
-
The effects of exogenous testosterone on sexuality and mood of normal men.J Clin Endocrinol Metab. 1992 Dec;75(6):1503-7. doi: 10.1210/jcem.75.6.1464655. J Clin Endocrinol Metab. 1992. PMID: 1464655 Clinical Trial.
-
Testosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality-of-life parameters vs. placebo in a population of men with type 2 diabetes.J Sex Med. 2013 Jun;10(6):1612-27. doi: 10.1111/jsm.12146. Epub 2013 Apr 3. J Sex Med. 2013. PMID: 23551886 Clinical Trial.
-
Sexual functioning in testosterone-supplemented patients treated for bilateral testicular cancer.Br J Urol. 1997 Mar;79(3):461-7. doi: 10.1046/j.1464-410x.1997.00027.x. Br J Urol. 1997. PMID: 9117232
-
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
-
Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.Expert Opin Drug Saf. 2013 Jan;12(1):81-90. doi: 10.1517/14740338.2013.742885. Epub 2012 Nov 22. Expert Opin Drug Saf. 2013. PMID: 23173718 Review.
Cited by
-
Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.Curr Psychiatry Rep. 2000 Jun;2(3):215-22. doi: 10.1007/s11920-996-0011-5. Curr Psychiatry Rep. 2000. PMID: 11122959 Review.
-
Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results.World J Urol. 2003 Nov;21(5):320-4. doi: 10.1007/s00345-003-0371-y. Epub 2003 Oct 29. World J Urol. 2003. PMID: 14586547
-
Sexual dysfunction and depression.Curr Psychiatry Rep. 2001 Jun;3(3):202-8. doi: 10.1007/s11920-001-0053-7. Curr Psychiatry Rep. 2001. PMID: 11353583 Review.
-
Testosterone replacement in men with sexual dysfunction.Cochrane Database Syst Rev. 2024 Jan 15;1(1):CD013071. doi: 10.1002/14651858.CD013071.pub2. Cochrane Database Syst Rev. 2024. PMID: 38224135 Free PMC article.
-
Risks versus benefits of testosterone therapy in elderly men.Drugs Aging. 1999 Aug;15(2):131-42. doi: 10.2165/00002512-199915020-00006. Drugs Aging. 1999. PMID: 10495072 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical